Patents by Inventor Benjamin FIEBIGER

Benjamin FIEBIGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROBIAL CONSORTIA
    Publication number: 20220378850
    Abstract: Provided herein are microbial strains isolated de novo. In some instances, the bacterial strains include genera, species, and/or strains of Lactobacillus johnsonii, Lactobacillus crispatus, Faecalibacterium prausnitzii, Akkermansia muciniphila, Bifidobacterium longum, and/or Bifidobacterium longum infantis strains. These bacterial strains can be used in the treatment of dysbiosis, inflammation, and other disorders.
    Type: Application
    Filed: April 22, 2022
    Publication date: December 1, 2022
    Inventors: Nikole KIMES, Ricardo Valladares, Benjamin Fiebiger, Susan V. Lynch
  • Microbial consortia
    Patent number: 11369644
    Abstract: Provided herein are microbial strains isolated de novo. In some instances, the bacterial strains include genera, species, and/or strains of Lactobacillus johnsonii, Lactobacillus crispatus, Faecalibacterium prausnitzii, Akkermansia muciniphila, Bifidobacterium longum, and/or Bifidobacterium longum infantis strains. These bacterial strains can be used in the treatment of dysbiosis, inflammation, and other disorders.
    Type: Grant
    Filed: October 9, 2020
    Date of Patent: June 28, 2022
    Assignees: SIOLTA THERAPEUTICS, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Nikole Kimes, Ricardo Valladares, Benjamin Fiebiger, Susan V. Lynch
  • COMPOSITIONS FOR DISEASE TREATMENT
    Publication number: 20210380651
    Abstract: The present disclosure provides methods and compositions comprising chimeric binding agents such as those comprising an Fc epsilon binding region and an Fc gamma binding region, and which may bind two or more of the receptors. The herein described methods and compositions may be used for treatment and prevention of various diseases and conditions, particularly IgE-mediated allergic and inflammatory diseases.
    Type: Application
    Filed: August 19, 2021
    Publication date: December 9, 2021
    Inventors: Nikole E. KIMES, Benjamin FIEBIGER, Ricardo VALLADARES
  • MICROBIAL CONSORTIA
    Publication number: 20210077541
    Abstract: Provided herein are microbial strains isolated de novo. In some instances, the bacterial strains include genera, species, and/or strains of Lactobacillus johnsonii, Lactobacillus crispatus, Faecalibacterium prausnitzii, Akkermansia muciniphila, Bifidobacterium longum, and/or Bifidobacterium longum infantis strains. These bacterial strains can be used in the treatment of dysbiosis, inflammation, and other disorders.
    Type: Application
    Filed: October 9, 2020
    Publication date: March 18, 2021
    Inventors: Nikole KIMES, Ricardo VALLADARES, Benjamin FIEBIGER, Susan V. LYNCH